Skip to main content Skip to navigation
Dermatological Sciences research is within the School of Translational Medicine
Dermatological Sciences

Publications

  • 2010

    Book contribution

    • Pilkington S, Rhodes LE. (2010). Omega-3 fatty acids and skin. In Krutmann J, Humbert P (Ed.), Nutrition for Healthy Skin: Strategies for Clinical and Cosmetic Practice. (pp. 91-107). Springer. eScholarID:3d842

  • 2009

    Book contribution

    • Haylett AA, Rhodes LE. (2009). Evaluation of the patient with photosensitivity. Allergy Frontiers: Diagnosis and Health Economics. Springer. eScholarID:3d1084

    Conference contribution

    • Gledhill K, Haylett AA, Brownrigg M, Masoodi M, Thody AJ, Nicolaou A, Rhodes LE, Tobin DJ. (2009). Leukocyte infiltration into human skin in response to UVR: Influence of skin photo-type?. eScholarID:2d2189

    Journal article

    • Harries MJ, Trueb RM, Tosti A, Messenger AG, Chaudhry I, Whiting DA, Sinclair R, Griffiths CEM, Paus RR. (2009). How not to get scar(r)ed: pointers to the correct diagnosis in patients with suspected primary cicatricial alopecia. Br J Dermatol, eScholarID:1d18484 | DOI:10.1111/j.1365-2133.2008.09008.x
    • Warren RB, Brown BC, Lavery D, Ashcroft DM, Griffiths CEM. (2009). Biologic therapies for psoriasis: practical experience in a U.K. tertiary referral centre. Br J Dermatol, 160, 162-169. eScholarID:1d18114 | DOI:10.1111/j.1365-2133.2008.08865.x
    • Warren RB, Smith R, Campalani E, Eyre SS, Smith CH, Barker JN, Worthington J, Griffiths CEM. (2009). Outcomes of methotrexate therapy for psoriasis and relationship to genetic polymorphisms. Br J Dermatol, 160 (2), 438-441. eScholarID:1d18204 | DOI:10.1111/j.1365-2133.2008.08898.x

  • 2008

    Journal article

    • Brown M, Teubner A, Shaffer J, Herrick AL. (2008). Home parenteral nutrition--an effective and safe long-term therapy for systemic sclerosis-related intestinal failure. Rheumatology (Oxford), 47 (2), 176-9. eScholarID:1d16930
    • Chikura B, Moore T, Manning J, Vail A, Herrick AL. (2008). Sparing of the thumb in Raynaud's phenomenon. Rheumatology (Oxford), 47 (2), 219-21. eScholarID:1d16928
    • Filer C, Ho PY, Smith R, Griffiths CEM, Young H, Worthington J, Bruce IN, Barton A. (2008). Investigation of association of the IL12B and IL23R genes with psoriatic arthritis. Arthritis Rheum, 58 (12), 3705-9. eScholarID:1d18217 | DOI:10.1002/art.24128
    • Harries M, Sinclair R, Macdonald-Hull S, Whiting D, Griffiths CEM, Paus RR. (2008). Management of primary cicatricial alopecias: options for treatment. Br J Dermatol, 159( 1), 1-22. eScholarID:1d18207 | DOI:10.1111/j.1365-2133.2008.08591.x
    • Hussain W, Ogden S, Lavery D, Griffiths CEM. (2008). Making a 'point' about the safe disposal of sharps in patients on biological therapies. Br J Dermatol, 159( 2), 491-2. eScholarID:1d18205 | DOI:10.1111/j.1365-2133.2008.08639.x
    • Jong, C, Finlay, A, Pearse, A, Kerr, A, Ferguson, J, Benton, E, Hawk, J, Sarkany, R, McMullen, E, Rhodes, LE, Farr, P, Anstey, A. (2008). The quality of life of 797 patients with photodermatoses. Br J Dermatol, 159, 192-197. eScholarID:1d17547 | DOI:10.1111/j.1365-2133.2008.08581.x
    • Kaufmann, R, Spelman, L, Weightman, W, Reifenberger, J, Szeimies, R, Verhaeghe, E, Kerrouche, N, Sorba, V, Villemagne, H, Rhodes, LE. (2008). Multicentre intraindividual randomized trial of topical methyl aminolaevulinate-photodynamic therapy vs. cryotherapy for multiple actinic keratoses on the extremities. Br J Dermatol, 158(5), 994-999. eScholarID:1d17549 | DOI:10.1111/j.1365-2133.2008.08488.x
    • Kirby B, Richards H, Mason D, Fortune D, Main C, Griffiths CEM. (2008). Alcohol consumption and psychological distress in patients with psoriasis. Br J Dermatol, 158( 1), 138-40. eScholarID:1d18195 | DOI:10.1111/j.1365-2133.2007.08299.x
    • Lübeck, R, Berneburg, M, Trelles, M, Friguet, B, Ogden, S, Esrefoglu, M, Kaya, G, Goldberg, D, Mordon, S, Calderhead, R, Griffiths, CEM, Saurat, J, Thappa, D. (2008). How best to halt and/or revert UV-induced skin ageing: strategies, facts and fiction. Exp Dermatol, 17( 3), 228-40. eScholarID:1d18210 | DOI:10.1111/j.1600-0625.2007.00665_1.x
    • Morton CA, McKenna KE, Rhodes LE. (2008). Guidelines for Topical Photodynamic Therapy: Update. On behalf of the British Association of Dermatologists Therapy Guidelines and Audit Subcommittee and the British Photodermatology Group. British Journal Of Dermatology, 159, 1245-66. eScholarID:1d28296
    • Murray AK, Moore T, King T, Herrick AL. (2008). Vasodilator iontophoresis a possible new therapy for digital ischaemia in systemic sclerosis? Rheumatology (Oxford), 47 (1), 76-79. eScholarID:1d16847 | DOI:10.1093/rheumatology/kem314
    • Ogden S, Griffiths CEM. (2008). Viewpoint 2. Exp Dermatol, 17( 3), 230-231. eScholarID:1d18202 | DOI:10.1111/j.1600-0625.2007.00665_2.x
    • Ogden S, Samuel M, Griffiths CEM. (2008). A review of tazarotene in the treatment of photodamaged skin. Clin Interv Aging, 3( 1), 71-6. eScholarID:1d18208
    • Pushpakom SP, Herrick AL, Kumar S, Worthington J. (2008). Polymorphisms in COL15 Gene Are Not Associated with Systemic Sclerosis. J Rheumatol, 35(2), 251-3. eScholarID:1d16929
    • Reich K, Griffiths CEM. (2008). The relationship between quality of life and skin clearance in moderate-to-severe psoriasis: lessons learnt from clinical trials with infliximab. Arch Dermatol Res, 300( 10), 537-44. eScholarID:1d18116 | DOI:10.1007/s00403-008-0885-7
    • Reich K, Sinclair R, Roberts G, Griffiths CEM, Tabberer M, Barker J. (2008). Comparative effects of biological therapies on the severity of skin symptoms and health-related quality of life in patients with plaque-type psoriasis: a meta-analysis. Curr Med Res Opin, 24( 5), 1237-54. eScholarID:1d18209 | DOI:10.1185/030079908X291985
    • Rich P, Griffiths CEM, Reich K, Nestle F, Scher R, Li S, Xu S, Hsu M, Guzzo C. (2008). Baseline nail disease in patients with moderate to severe psoriasis and response to treatment with infliximab during 1 year. J Am Acad Dermatol, 58( 2), 224-31. eScholarID:1d18191 | DOI:10.1016/j.jaad.2007.07.042
    • Richards H, Fortune D, Griffiths CEM. (2008). The Greater Patient concept. Br J Dermatol, 158( 1), 176-8. eScholarID:1d18198 | DOI:10.1111/j.1365-2133.2007.08247.x
    • Richards HL, Ling T, Evangelou G, Brooke RCC, Gibbs NK, Fortune DG, Rhodes LE. (2008). Evidence of high levels of anxiety and depression in polymorphic light eruption and their association with clinical and demographic variables. Br J Dermatol, 159, 439-444. eScholarID:1d17546 | DOI:10.1111/j.1365-2133.2008.08623.x
    • Saraceno R, Nistico S, Capriotti E, de Felice C, Rhodes LE, Chimenti S. (2008). Monochromatic excimer light (308 nm) in the treatment of prurigo nodularis. Photodermatol Photoimmunol Photomed, 24( 1), 43-45. eScholarID:1d17550
    • Skvara, H, Dawid, M, Kleyn, E, Wolff, B, Meingassner, J, Knight, H, Dumortier, T, Kopp, T, Fallahi, N, Stary, G, Burkhart, C, Grenet, O, Wagner, J, Hijazi, Y, Morris, R, McGeown, C, Rordorf, C, Griffiths, CEM, Stingl, G, Jung, T. (2008). The PKC inhibitor AEB071 may be a therapeutic option for psoriasis. J Clin Invest, 118( 9), 3151-9. eScholarID:1d18118 | DOI:10.1172/JCI35636
    • Smith, R, Warren, RB, Eyre, SS, Ke, X, Young, H, Allen, M, Strachan, D, McArdle, W, Gittins, M, Barker, J, Griffiths, CEM, Worthington, J. (2008). Polymorphisms in the PTPN22 region are associated with psoriasis of early onset. Br J Dermatol, 158(5), eScholarID:1d17071 | DOI:10.1111/j.1365-2133.2008.08482.x
    • van de Kerkhof P, Barker J, Griffiths CEM, Kragballe K, Mason J, Menter A, Papp K. (2008). Psoriasis: consensus on topical therapies. J Eur Acad Dermatol Venereol, 22( 7), 859-70. eScholarID:1d18192 | DOI:10.1111/j.1468-3083.2007.02534.x
    • Warren RB, Brown B, Griffiths CEM. (2008). Topical treatments for scalp psoriasis. Drugs, 68( 16), 2293-302. eScholarID:1d18113
    • Warren RB, Chalmers R, Griffiths CEM, Menter A. (2008). Methotrexate for psoriasis in the era of biological therapy. Clin Exp Dermatol, 33( 5), 551-4. eScholarID:1d18115 | DOI:10.1111/j.1365-2230.2008.02976.x
    • Warren RB, Griffiths CEM. (2008). Systemic therapies for psoriasis: methotrexate, retinoids, and cyclosporine. Clin Dermatol, 26( 5), 438-47. eScholarID:1d18117 | DOI:10.1016/j.clindermatol.2007.11.006
    • Warren RB, Smith R, Campalani E, Eyre SS, Smith CH, Barker JN, Worthington J, Griffiths CEM. (2008). Genetic variation in efflux transporters influences outcome to methotrexate therapy in patients with psoriasis. J Invest Dermatol, 128 (8), 1925-1929. eScholarID:1d17073
    • Wolf, N, Quaranta, M, Prescott, N, Allen, M, Smith, R, Burden, A, Worthington, J, Griffiths, CEM, Mathew, C, Barker, J, Capon, F, Trembath, R. (2008). Psoriasis is associated with pleiotropic susceptibility loci identified in type II diabetes and Crohn disease. J Med Genet, 45 (2), 114-6. eScholarID:1d18197 | DOI:10.1136/jmg.2007.053595
    • Woods, A, Rutter, K, Gardner, L, Lewis, V, Saxena, S, George, S, Chalmers, R, Griffiths, CEM, Speight, E, Anstey, A, Ronda, L, McGibbon, D, Barker, J, Smith, C. (2008). Inpatient management of psoriasis: a multicentre service review to establish national admission standards. Br J Dermatol, 158( 2), 266-72. eScholarID:1d18193 | DOI:10.1111/j.1365-2133.2007.08338.x
    • Yesudian P, Berry JL, Wiles S, Hoyle S, Young D, Haylett AA, Rhodes LE, Davies P. (2008). The effect of ultraviolet B-induced vitamin D levels on host resistance to Mycobacterium tuberculosis: a pilot study in immigrant Asian adults living in the United Kingdom. Photodermatol Photoimmunol Photomed, 24( 2), 97-8. eScholarID:1d17548

    Journal contribution

    • Smith R, Warren RB, Eyre SS, Ho PY, Ke X, Young H, Griffiths CEM, Worthington J. (2008). Polymorphisms in the IL-12beta and IL-23R genes are associated with psoriasis of early onset in a UK cohort. J Invest Dermatol, 128( 5), eScholarID:17d699

    Report

    • Ho, P, Barton, A, Worthington, J, Plant, D, Griffiths, CEM, Young, H, Bradburn, P, Thomson, W, Silman, A, Bruce, I. (2008). Investigating the role of the HLA-Cw*06 and HLA-DRB1 genes in susceptibility to psoriatic arthritis: comparison with psoriasis and undifferentiated inflammatory arthritis. ( 67( 5), ). England: Academic Press. eScholarID:5d78 | DOI:10.1136/ard.2007.071399

  • 2007

    Book contribution

    • Rhodes LE, Lim Henry W. (2007). The acute effects of ultraviolet radiation on the skin. Principles and Practice of Photodermatology. eScholarID:3d802

    Journal article

    • Anderson ME, Moore TL, Lunt M, Herrick AL. (2007). The 'distal-dorsal difference': a thermographic parameter by which to differentiate between primary and secondary Raynaud's phenomenon. Rheumatology (Oxford), 46(3), 533-8. eScholarID:1d14366
    • CA Denton, PA Merkel, DE Furst, V Khanna, Emery, P, VM Hsu, N Silliman, J Streisand, J Powell, A Akesson, A Coppock, F van den Hoogen, Herrick, AL, MD Mayes, D Veale, S Ledbetter, JH Korn, CM Black, JR Seibold. (2007). Recombinant human anti-TGFbeta1 antibody therapy in systemic sclerosis: a multicentre, randomised, placebo-controlled Phase I/II trial of CAT-192. Arthritis and Rheumatism, 56(1), 323-333. eScholarID:1d15034 | DOI:10.1002/art.22289
    • Cordingley ME, Hyde C E, Peters S, Vernon B, Bundy C. (2007). Undergraduate medical students' exposure to clinical ethics: a challenge to the development of professional behaviours? Medical Education, 41, eScholarID:1d14728 | DOI:10.1111/j.1365-2923.2007.02943.x
    • Gazi, H, Pope, J, Clements, P, Medsger, T, Martin, R, Merkel, P, Kahaleh, B, Wollheim, F, Baron, M, Csuka, M, Emery, P, Belch, J, Hayat, S, Lally, E, Korn, J, Czirjak, L, Herrick, AL, Voskuyl, A, Bruehlmann, P, Inanc, M, Furst, D, Black, C, Ellman, M, Moreland, L, Rothfield, N, Hsu, V, Mayes, M, McKown, K, Krieg, T, Siebold, J. (2007). Outcome measurements in scleroderma: results from a delphi exercise. J Rheumatol, 34( 3), 501-9. eScholarID:1d15803
    • Griffiths CEM, JNWN Barker. (2007). Psoriasis: background and clinical features. The Lancet, eScholarID:1d15819
    • Griffiths, CEM, E Christophers, JNWN Barker, Chalmers, RJG, S Chimenti, GG Krueger, C Leonardi, A Menter, J-P Ortonne, L Fry. (2007). A classification of psoriasis vulgaris according to phenotype. British Journal of Dermatology, 156, 258-262. eScholarID:1d15049
    • Janssens AS, Pavel S, Ling, T, Winhoven S, Anastassopolou L, Stratigos AJ, Antoniou C, Diepgen TL, Bruckner T, de Gruijl FR, Rhodes, LE. (2007). Susceptibility to UVA and UVB provocation does not correlate with disease severity of polymorphic light eruption. Archives Of Dermatology, 143, 599-607. eScholarID:1d27536
    • Lawson VL, Bundy C, Harvey JN. (2007). Development of the Diabetes Health Threat Communication Questionnaire (DHTCQ). Patient Education & Counselling, eScholarID:1d16087
    • Lawson VL, Bundy C, Harvey JN. (2007). The Influence of Health Threat Communication and Personality Traits on Personal Models of Diabetes in Newly Diagnosed Diabetic Patients. Diabetic Medicine, eScholarID:1d16088
    • Lawson VL, Lyne PA, Bundy C, Harvey JN. (2007). The role of personal models, coping and evaluation in care-seeking among people with type 1 diabetes. Psychology & Health, 22 (2), 175-191. eScholarID:1d16085
    • M Schmuth, Watson REB, D Deplewski, S Dubrac, SS Zouboulis, Griffiths CEM. (2007). Nuclear hormone receptors in human skin. Hormone and Metabolic Research, 39, 96-105. eScholarID:1d15818
    • Malik MA, Bayat A, Jury F, Kay P, Ollier WER. (2007). Genetic susceptibility to total hip arthroplasty failure-positive association with mannose-binding lectin. J Arthroplasty, 22(2), 265-70. eScholarID:1d15753
    • Malik MA, Jury F, Bayat A, Ollier WER, Kay PR. (2007). Genetic susceptibility to total hip replacement failure- Preliminary study on the influence of matrix metalloproteinase-1, interleukin-6 and vitamin D receptor polymorphisms. Ann Rheum Dis, 66, 1116-1120. eScholarID:1d15763
    • Rhodes, LE, de Rie MA, Leifsdottir R, Yu RC, Bachmann I, Goulden V, Wong GAE, Richard M-A, Anstey A, Wolf P. (2007). Five year follow up of a randomized prospective trial of topical methyl aminolevulinate-photodynamic therapy versus surgery for nodular basal cell carcinoma. Archives Of Dermatology, 143, 1131-1136. eScholarID:1d27462
    • Rice, G, Newman, WG, Dean, J, Patrick, T, Parma, R, Flintoff, K, Robins, P, Harvey, S, Hollis, T, O'Hara, A, Herrick, AL, Bowden, AP, Perrino, FW, Lindahl, T, Barnes, DE, Crow, YJ. (2007). Heterozygous mutations in TREX1 cause familial chilblain lupus and dominant Aicardi-Goutieres syndrome. American Journal of Human Genetics, 80(4)(4), eScholarID:1d15528
    • Richards HL, Ling T, Evangelou G, Brooke RCC, Huber K, Gibbs NK, Fortune D, Rhodes LE. (2007). Psychologic distress in polymorphous light eruption and its relationship to patients' beliefs about their condition. Journal of the American Academy of Dermatology, 56, 426-31. eScholarID:1d14646 | DOI:10.1016/j.jaad.2006.10.035
    • Storey A, Rogers J, McArdle F, Jackson M, Rhodes LE. (2007). Conjugated linoleic acids (CLA) modulate UVR-induced IL-8 and PGE2 in human skin cells: potential of CLA isomers in nutritional photoprotection. Carcinogenesis, 28, 1329-1333. eScholarID:1d15413
    • Watson REB, R Poddar, JM Walker, I McGuill, LM Hoare, Griffiths CEM, O'Neill CA. (2007). Altered claudin expression is a feature of chronic plaque psoriasis. Journal of Pathology, 212, 450-8. eScholarID:1d15823
    • Watson REB, S P Long, Bowden JJ, Bastrilles J, S P Barton, Griffiths CEM. (2007). Repair of photoaged dermal matrix by topical application of cosmetic anti-ageing products. British Journal Of Dermatology, eScholarID:1d27407
    • Wittkowski A, Richards H.L, Williams J, Fortune D, Griffiths CEM, Main C.J. (2007). An Examination of the Psychometric Properties and Factor Structure of the Feelings of Stigmatization Questionniare. Journal of Clinical Psychology in Medical Settings, 14, 248-257. eScholarID:1d13727
    • Y Zhao, A Terron-Kwiatkowski, H Liau, SP Lee, MH Allen, PR Hull, LM Campbell, RC Trembath, F Capon, Griffiths, CEM, D Burden, R McManus, R Hughes, B Kirby, O Fitzgerald, D Kane, JNWN Barker, CAN Palmer, AD Irvine, WHI McLean. (2007). Filaggrin null alleles are not associated with psoriasis patients. Journal of Investigative Dermatology, eScholarID:1d15821
    • Yohannes AM, Yalfani A, Doherty P, Bundy C. (2007). Predictors of Dropout from an Outpatient Cardiac Rehabilitation Programme. J Clinical Rehabilitation, eScholarID:1d16086

    Journal contribution

    • Moore T, Vail A, Herrick AL. (2007). Assessment of digital vascular structure and function in response to bosentan in patients with systemic sclerosis-related Raynaud's phenomenon. Rheumatology (Oxford), 46(2), 363-4. eScholarID:17d674

    Report

    • Dunkin C, Pleat J, Gillespie P, Tyler M, Roberts A, McGrouther D. (2007). Scarring occurs at a critical depth of skin injury: precise measurement in a graduated dermal scratch in human volunteers. ( 119( 6), ). United States: Academic Press. eScholarID:5d75 | DOI:10.1097/01.prs.0000258829.07399.f0

  • 2006

    Book contribution

    • Rhodes LE, Storey A. (2006). Essential fatty acids: biological functions and potential applications in the skin. Dry Skin and Moisturisers: Chemistry and Function. 2nd edition. Eds. Loden M, Maibach HI.CRC Press, Boca Raton. Academic Press: CRC Press. eScholarID:3d404

    Conference contribution

    • Tye J, Blackburn A, Winhoven SM, Brownrigg M, Rhodes LE, Gibbs NK. (2006). UVB-induced caspase-3 expression and loss of CD1a+ Langerhans' cells in human skin are independantly correlated with erythemal sensitivity. Academic Press. eScholarID:2d1944

    Journal article

    • A Roberts, C Dunkin, MPH Tyler, McGrouther D, J Pleat. (2006). The Dermal Scratch- a Volunteer study of partial thickness wound healing. Plastic and Reconstructive Surgery, eScholarID:1d13110
    • Ashcroft DM, Seston EM, Griffiths CEM. (2006). Trade-offs between the benefits and risks of drug treatment for psoriasis: a discrete choice experiment with U.K. dermatologists. British Journal Of Dermatology, 155, 1236-1241. eScholarID:1d27328
    • Black HS, Rhodes LE. (2006). The potential of omega-3 fatty acids in the prevention of non-melanoma skin cancer. Cancer Prevention and Detection, 30 (3), 224-232. eScholarID:1d12954
    • Brooke RCC, Sinha A, Sidhu M, Watson REB, Church MK, Friedmann PS, Clough GF, Rhodes LE. (2006). Histamine is released following aminolevulinic acid (ALA)-photodynamic therapy of human skin and mediates an ALA-dose related immediate inflammatory response. Journal Of Investigative Dermatology, 126, 2296-2301. eScholarID:1d27145 | DOI:10.1038/sj.jid.5700449
    • Bryden, AA, Moseley H, Ibbotson S, Chowdhury MMU, Beck, MH, Bourke J, English J, Farr P, Foulds I, Gawkrodger D, George S, Orton D, Shaw S, McFadden J, Norris P, Podmore P, Powell S, Rhodes, LE, Sansom J, Wilkinson M, Van Weeldon H, Ferguson, JE. (2006). Photopatch testing: Results of the UK multicentre Photopatch Study Group. British Journal Of Dermatology, 155, 737-747. eScholarID:1d27161
    • CO Mendonca, Griffiths CEM. (2006). Clindamycin and rifampicin combination therapy for hidradenitis suppurativa. British Journal of Dermatology, 154, 977-978. eScholarID:1d12976
    • Davies CA, Jeziorska M, Freemont AJ, Herrick AL. (2006). Expression of osteonectin and matrix Gla protein in scleroderma patients with and without calcinosis. Rheumatology, 45(11), 1349-1355. eScholarID:1d13193 | DOI:10.1093/rheumatology/kei277
    • Davies CA, Jeziorska M, Freemont AJ, Herrick AL. (2006). The differential expression of VEGF, VEGFR-2, and GLUT-1 proteins in disease subtypes of systemic sclerosis. Hum Pathol, 37(2), 190-197. eScholarID:1d12933
    • E Campalani, MH Allen, D Fairhurst, Young, H, CO Mendonca, AD Buren, Griffiths, CEM, MA Crook, JN Barker, CH Smith. (2006). Apolipoprotein E gene polymorphisms are associated with psoriasis but do not determine disease response to acitretin. British Journal of Dermatology, 154, 345-352. eScholarID:1d12875
    • E Christophers, Griffiths CEM, G Gaitanis, P van de Kerkhof. (2006). The unmet treatment need for moderate to severe psoriasis: results of a survey and chart review. Journal of European Academy of Venereology, 20, 921-925. eScholarID:1d13848
    • Griffiths CEM, A Katsambas, BAC Dijkmans, AY Finlay, VC Ho, A Johnston, T Luger, U Mrowietz, K Thestrup-Pederson. (2006). Update on the use of ciclosporin in immune-mediated dermatoses. British Journal of Dermatology, 155, 1-16. eScholarID:1d12908
    • Griffiths CEM, Andrew Finlay, Colin Fleming, Jonathan Barker, Fabienne Mizzi, Stephanie Arsonnaud. (2006). A randomized, investigator-masked clinical evaluation of the efficacy and safety of clobetasol propionate 0.05% shampoo and tar blend 1% shampoo in the treatment of moderate to severe scalp psoriasis. Journal of Dermatological Treatment, 17, 90-95. eScholarID:1d13335
    • Griffiths CEM, H Taylor, S I Collins, Hobson J, P A Collier, Chalmers RJG, Stewart EJC, P Dey. (2006). The impact of psoriasis guidelines on the appropriateness of referral from primary to secondary care: a randomised controlled trial. British Journal of Dermatology, 155, 393-400. eScholarID:1d13478
    • Griffiths CEM, L Iaccarino, L Naldi, N Pipitone, C Salvarani, A Doria. (2006). Psoriasis and psoriatic arthritis: Immunological aspects and therapeutic guidelines. Clinical and Experimental Rheumatology, 24, S72-S78. eScholarID:1d12878
    • GSS Atwal, LK Manku, Griffiths CEM, Polson DW. (2006). Striae gravidarum in primiparae. British Journal of Dermatology, 155, 965-9. eScholarID:1d13482
    • Henderson J, Terenghi G, McGrouther D, Ferguson M. (2006). The reinnervation pattern of wounds and scars may explain their sensory symptoms. J Plast Reconstr Aesthet Surg, 59( 9), 942-50. eScholarID:1d13763
    • Hoyles, R, Ellis, R, Wellsbury, J, Lees, B, Newlands, P, Goh, N, Roberts, C, Desai, S, Herrick, AL, McHugh, N, Foley, N, Pearson, S, Emery, P, Veale, D, Denton, C, Wells, A, Black, C, du Bois, R. (2006). A multicenter, prospective, randomized, double-blind, placebo-controlled trial of corticosteroids and intravenous cyclophosphamide followed by oral azathioprine for the treatment of pulmonary fibrosis in scleroderma. Arthritis Rheum, 54( 12), eScholarID:1d14369
    • K Reich, FO Nestle, K Papp, JP Ortonne, Y Wu, M Bala, R Evans, C Guzzo, S Li, LT Dooley, Griffiths, CEM. (2006). Improvement in quality of life with infliximab induction and maintenance therapy in patients with moderate-to-severe psoriasis: a randomized controlled trial. British Journal of Dermatology, 154, 1161-1168. eScholarID:1d12905
    • KE McKenna, Whittaker SS, Rhodes LE, P Taylor, Lloyd J, Ibbotson S, Russell-Jones R. (2006). Evidence based practice of photopheresis 1987-2001: Report of a workshop of the British Photodermatology Group and the UK skin Lymphoma Group. British Journal of Dermatology, 154 (1), 7-20. eScholarID:1d10949
    • Kleyn CE, Griffiths CEM. (2006). Infliximab for the treatment of psoriasis. Expert Opinion on Biological Therapy, 6, 797-805. eScholarID:1d13492
    • Knight KK, McGowan L, Dickens C, Bundy C. (2006). A systematic review of the use of motivational interviewing in physical healthcare settings. British Journal of Health Psychology, 11(2), 319-312. eScholarID:1d26975 | DOI:10.1348/135910705X52516
    • L Stewart, A Roberts, Warren RB, Griffiths CEM. (2006). Using biological therapies for psoriasis and other inflammatory dermatoses. Dermatology in Practice, 14, 18-21. eScholarID:1d13847
    • Ling TC, Richards, HE, Janssens AS, Anastassopoulou L, Antoniou C, Aubin F, Diepgen TL, Fazakerley R, de Gruijl FR, Jansen CT, Pavel S, Smedley A, Stratigos AJ, Webb AR, Gibbs, NK, Rhodes, LE. (2006). Seasonal and Latitudinal Impact of Polymorphic Light Eruption on Quality of Life. Journal Of Investigative Dermatology, 126 (7), 1648-1651. eScholarID:1d27007 | DOI:10.1038/sj.jid.5700306
    • Malik MA, Bayat A, Jury F, Ollier WER, Kay PR, Kay P. (2006). Genetic susceptibility to hip arthroplasty failure-association with the RANK/OPG pathway. Int Orthop, 30(3), 177-181. eScholarID:1d13221
    • Marie Cumberbatch, M Singh, Rebecca Dearman, Young H, I Kimber, Griffiths CEM. (2006). Impaired Langerhans' cell migration in psoriasis. The Journal of Experimental Medicine, 203, 953-960. eScholarID:1d12906 | DOI:10.1084/jem.20052367
    • Minal Singh, Griffiths CEM. (2006). The use of retinoids in the treatment of photoaging. Dermatologic Therapy, 19, 297-305. eScholarID:1d13849
    • MJ Harries, E McMullen, Griffiths CEM. (2006). Pyoderma gangrenosum masquerading as dermatitis artefacta. Archives of Dermatology, 142, 1509-10. eScholarID:1d12910
    • Murray AK, Moore TL, King TA, Herrick AL. (2006). Abnormal microvascular response is localised to the digits in patients with systemic sclerosis. Arthritis and Rheumatism, 54, 1952-1960. eScholarID:1d12903 | DOI:10.1002/art.21911
    • N MacDonald, Marie Cumberbatch, M Singh, JG Moggs, G Orphanides, Rebecca Dearman, Griffiths CEM. (2006). Proteomic analysis of suction blister fluid isolated from human skin. Clin Exp Derm, 31, 445-448. eScholarID:1d12907
    • O'Ceallaigh S, Herrick SE, Bluff J, McGrouther D, Ferguson M. (2006). Quantification of total and perfused blood vessels in murine skin autografts using a fluorescent double-labeling technique. Plast Reconstr Surg, 117( 1), 140-51. eScholarID:1d12981
    • Plant D, Watson REB, Young H, Worthington J, Griffiths CEM. (2006). The CX3CL1-CX3CR1 system and psoriasis. Experimental Dermatology, 15 (11), 900-903. eScholarID:1d13538
    • R Saraceno, Griffiths CEM. (2006). A European perspective on the challenges of managing psoriasis. Journal of the American Academy of Dermatology, 54, S81-S84. eScholarID:1d12879
    • R Saraceno, Kleyn CE, Terenghi G, Griffiths CEM. (2006). The role of neuropeptides in psoriasis. British Journal of Dermatology, 154, 876-882. eScholarID:1d13480
    • Richards HE, Fortune DG, Griffiths CEM. (2006). Adherence to treatment in patients with psoriasis. Journal of European Acadamy of Dermatology and Venerology, 20, 370-379. eScholarID:1d11187
    • RK Hoyles, RW Ellis, J Wellsbury, B Lees, P Newlands, Roberts, C, S Desai, Herrick, AL, NJ McHugh, NM Foley, SB Pearson, P Emery, DJ Veale, CP Denton, AU Wells, CM Black, RM du Bois. (2006). Fibrosing Alveolitis in Scleroderma Trial (FAST) - a multi-centre, prospective, randomised, double-blind, placebo-controlled trial of treatment with corticosteroids and intravenous cyclophosphamide followed by oral azathioprine. Arthritis and Rheumatism, 54(12), 3962-3970. eScholarID:1d15043 | DOI:10.1002/art.22204
    • SE Clements, S Abdul-Ghaffer, Griffiths CEM. (2006). Biological therapy for psoriasis. Br J of Hospital Medicine, 67, 184-187. eScholarID:1d12904
    • Towey MG, Bundy C, Cordingley ME. (2006). Psychological and Social Interventions in the Menopause. Current Opinion in Obstetrics and Gynecology, 18(4), 413-417. eScholarID:1d12935
    • Tsoureli-Nikita E, Watson REB, Griffiths CEM. (2006). Photoageing: The darker side of the sun. Photochemical and Photobiological Sciences, 5, eScholarID:1d11086
    • Warren RB, Griffiths CEM. (2006). Anti-TNF drugs in dermatology and inflammatory bowel disease - Where are we going? Future Prescriber Article, 7, 1-7. eScholarID:1d12880
    • Wong JKF, Bennett W, Ferguson M, McGrouther D. (2006). Microscopic and histological examination of the mouse hindpaw digit and flexor tendon arrangement with 3D reconstruction. J Anat, 209( 4), 533-45. eScholarID:1d14572
    • Wong JKF, Cerovac S, Ferguson MW.J, McGrouther D. (2006). The Cellular effect of a single interrupted suture on tendon. Journal of Hand Surgery, 31B, 358-367. eScholarID:1d13109 | DOI:10.1016/j.jhsb.2006.03.162
    • Yalfani A, Yohannes AM, Doherty P, Brett, J & Bundy C. (2006). Perceptions of Healthcare Staff in Relation to Referral for Cardiac Rehabilitation. Br J Cardiology, 13(2), eScholarID:1d16084
    • Young, H, Angela M Summers, Ian Read, David A Fairhurst, Plant, D, Emanuela Campalani, Catherine H Smith, Jonathan NWN Barker, Michael J Detmar, Brenchley, PEC, Griffiths, CEM. (2006). Interaction between genetic control of vascular endothelial growth factor production and retinoid responsiveness in psoriasis. Journal of investigative dermatology, 126, 453-459. eScholarID:1d26801 | DOI:10.1038/sj.jid.5700096

  • 2005

    Book contribution

    • C Mendonca, Griffiths CEM. (2005). Psoriasis: future drugs. Medicine. ( 33:1, pp. 56-57). Academic Press. eScholarID:3d388

    Conference contribution

    • M Bock, L Anastopolou, C Antoniou, F Aubin, T Bruckner, B Faivre, Gibbs, NK, FR de Gruijl, C Jansen, AS Jansens, S Niemela, Ling, T, S Pavel, Rhodes, LE, CA Stratigos, TL Diepgen. (2005). Life time prevalence and characteristics of photodermatoses in Europe. Presented at European Society for Dermatological Research Annual Conference. Academic Press. eScholarID:2d2484
    • Morley SM, O'Grady CC, Brown SB, Rhodes LE. (2005). A novel antimicrobial photodynamic therapy approach to treat chronic ulcers. Presented at British Society for Investigative Dermatology Annual Conference. Academic Press. eScholarID:2d1969
    • Winhoven SM, Blackburn A, Griffiths CEM, Gibbs NK. (2005). Paul Langerhans: the man and 'his' cell. Academic Press. eScholarID:2d1745

    Journal article

    • A V Anstey, R M Azurdia, Rhodes LE, A D Pearse, P E Bowden. (2005). Photosensitive Smith-Lemli-Opitz syndrome is not caused by a single gene mutation: analysis of the gene encoding 7-dehydrocholesterol reductase in five U.K. families. British Journal Of Dermatology, 153 (4), 774-9. eScholarID:1d26605
    • AB Gottlieb, Griffiths, CEM, VC HO, M Lahfa, U Mrowietz, DF Murrell, JP Ortonne, G Todd, R Cherill, I Marks, S Emady-Azar, CF Paul. (2005). Oral pimecrolimus in the treatment of moderate to severe chronic plaque-type psoriasis: a double-blind, multicentre, randomized, dose-finding trial. British Journal of Dermatology, 152, 1219-27. eScholarID:1d10932
    • Bayat A, Arscott G, Ollier WER, McGrouther D, Ferguson M. (2005). Keloid disease: clinical relevance of single versus multiple site scars. Br J Plast Surg, 58( 1), 28-37. eScholarID:1d11726
    • Bayat A, McGrouther D. (2005). Clinical management of skin scarring. Skinmed, 4( 3), 165-73. eScholarID:1d12982
    • Bayat A, Walter J, Bock O, Mrowietz U, Ollier WER, Ferguson M. (2005). Genetic susceptibility to keloid disease: mutation screening of the TGFbeta(3) gene. Br J Plast Surg, 58( 7), 914-21. eScholarID:1d11714
    • Bayat A, Walter J, Lamb H, Marino M, Ferguson M, Ollier WER. (2005). Mitochondrial mutation detection using enhanced multiplex denaturing high-performance liquid chromatography. Int J Immunogenet, 32( 3), 199-205. eScholarID:1d11718
    • Bayat A, Walter J, Lambe H, Watson J, Stanley JK, Marino M, Ferguson M, Ollier WER. (2005). Identification of a novel mitochondrial mutation in Dupuytren's disease using multiplex DHPLC. Plast Reconstr Surg, 115( 1), 134-41. eScholarID:1d11728
    • Bulstrode N, Mudera V, McGrouther D, Grobbelaar A, Cambrey A. (2005). 5-fluorouracil selectively inhibits collagen synthesis. Plast Reconstr Surg, 116( 1), 209-21; discussion 2. eScholarID:1d12128 | DOI:10.1097/01.PRS.0000169701.16509.D6
    • Cheema U, Brown R, Mudera V, Yang S, McGrouther D, Goldspink G. (2005). Mechanical signals and IGF-I gene splicing in vitro in relation to development of skeletal muscle. J Cell Physiol, 202( 1), 67-75. eScholarID:1d12127 | DOI:10.1002/jcp.20107
    • DA Fairhurst, Ashcroft DM, Griffiths CEM. (2005). Optimal Management of Severe Plaque Form of Psoriasis. American Journal of Clinical Dermatology, 6, 283-94. eScholarID:1d25906
    • DG Fortune, Richards HL, Griffiths CEM, Main CJ. (2005). Worry and pathological worry in patients with psoriasis: cross sectional and longitudinal analysis of the Penn State Worry Questionnaire in four samples of patients. Journal of Clinical Psychology in Medical Settings, 12, 143-152. eScholarID:1d10839
    • DG Fortune, Richards HL, Griffiths CEM. (2005). Psychological factors in psoriasis: consequences, mechanisms and interventions. Dermatology Clinics, 23, 681-694. eScholarID:1d10842
    • Fortune D, Richards HL, Griffiths CEM, Main CJ. (2005). Adversarial growth in patients undergoing treatment for psoriasis: A prospective study of the ability of patients to construe benefits from negative events. Psychology, Health and Medicine, 10, 44-56. eScholarID:1d9246
    • G Evangelou, SR Murdoch, I Palmaris, Rhodes LE. (2005). Photoaggravated pityriasis rubra pilaris. Photodermatol Photoimmunol Photomed, 21 (5), 272-4. eScholarID:1d10953
    • GG Krueger, RG Langley, AY Finlay, Griffiths CEM, JM Woolley, D Lalla, A Jahreis. (2005). Interaction between Genetic Control of Vascular Endothelial Growth Factor Production and Retinoid Responsiveness in Psoriasis. Journal of Investigative Dermatology, 153, 1192-1199. eScholarID:1d12877
    • Griffiths CEM, Dearman RJ, Cumberbatch M, Kimber I. (2005). Cytokines and langerhans cell mobilisation in mouse and man. Cytokine, 32(2), 67-70. eScholarID:1d11189
    • Griffiths CEM, S Maddin, O Wiedow, R Marks, AE Donald. (2005). Treatment of photoaged skin with a cream containing 0.05% isotretinoin and sunscreens. Journal Dermatoligical Treatment, 16, 79-86. eScholarID:1d10943
    • Griffiths CEM. (2005). Ciclosporin in psoriasis consensus statement: reply from authors. British Journal of Dermatology, 152, eScholarID:1d10935
    • Griffiths CEM. (2005). Controversies in experimental dermatology. Experimental Dermatology, 14, 398-9. eScholarID:1d10936
    • Grueger GG, Langley RG, Finlay AY, Griffiths CEM, Woolley JM, Lalla D, Jahreis A. (2005). Patient-Reported outcomes of psoriasis improvement with Etanercept therapy: Results of a randomized phase 3 trial. British Journal of Dermatology, eScholarID:1d11188
    • Harries M, Chalmers RJG, Griffiths CEM. (2005). Fumaric acid esters for severe psoriasis: a retrospective review of 58 cases. Br J Dermatol, 153( 3), 549-51. eScholarID:1d11977
    • Hinks, AM, Barton, A, John, S, Bruce, IN, Hawkins, C, Griffiths, CEM, Donn, RP, Thomson, W, Silman, AJ, Worthington, J. (2005). Association between the PTPN22 gene and rheumatoid arthritis and juvenile idiopathic arthritis in a UK population: further support that PTPN22 is an autoimmunity gene. Arthritis Rheum, 52( 6), 1694-9. eScholarID:1d11755 | DOI:10.1002/art.21049
    • Ho, PY, Bruce, IN, Silman, AJ, Symmons, D, Newman, WG, Young, H, Griffiths, CEM, John, S, Worthington, J, Barton, A. (2005). Evidence for common genetic control in pathways of inflammation for Crohn's disease and psoriatic arthritis. Arthritis Rheum, 52( 11), 3596-3602. eScholarID:1d11751
    • K Papp, S Tyring, M Lahfa, J Prinz, Griffiths CEM, AM Nakanishi, R Zitnik, P van de Kerkhof. (2005). A Global Phase 3 study of etanercept in psoriasis: safety, efficacy, and effect of dose reduction. British Journal of Dermatology, 152, 1304-12. eScholarID:1d10933
    • Kristian Reich, Frank O Nestle, Kim Papp, Jean-Paul Ortonne, Robert Evans, Cynthia Guzzo, Shu Li, Lisa T Dooley, Griffiths CEM. (2005). Infliximab induction and maintenance therapy for moderate-to-severe psoriasis: a phase III, multicentre, double-blind trial. Lancet, 366, 1367-1374. eScholarID:1d11574 | DOI:10.1016/S0140-6736(05)66916-4
    • L Naldi, Griffiths CEM. (2005). Traditional therapies in the management of moderate to severe chronic plaque psoriasis: an assessment of the benefits and risks. British Journal of Dermatology, 152, 597-615. eScholarID:1d10937
    • Lovatt, T, Lear, JT, Bastrilles, J, Wong, C, Griffiths, CEM, Samarasinghe, V, Roebuck, J, Ramachandran, S, Smith, A, Jones, P, Fryer, A, Strange, R. (2005). Associations between ultraviolet radiation, basal cell carcinoma site and histology, host characteristics, and rate of development of further tumors. J Am Acad Dermatol, 52( 3 Pt 1), 468-73. eScholarID:1d11945
    • M Allen, M Ameen, J Evans, C Veal, J Leman, AM Marsland, D Burden, Griffiths, CEM, RC Trembath, JNWN Barker. (2005). The major psoriasis susceptibility locus PSORS1, is not a risk factor for late onset psoriasis. Journal of Investigative Dermatology, 124, 103-6. eScholarID:1d9452
    • Murray AK, Attrill D, Dickinson MR. (2005). Qualitative assessment of surface topographyof XeCl laser etched NiCr alloy. Dental Materials, 21, eScholarID:1d12873
    • Murray AK, Attrill D, Dickinson MR. (2005). The effects of XeCl laser etching of Ni-Cr alloy on bond strengths to composite resin: a comparison with sandblasting procedures. Dental Materials, 21, 538-544. eScholarID:1d12975
    • Murray AK, Herrick AL, Gorodkin RE, Moore TL, King T. (2005). Possible therapeutic use of vasodilator iontophoresis. Microvascular Research, 69, 89-94. eScholarID:1d11092 | DOI:10.1016/j.mvr.2005.01.005
    • Murray AK, Herrick AL, Moore TL, King TA, Griffiths CEM. (2005). Dual wavelength (532 and 633nm) laser Doppler imaging of plaque psoriasis. British Journal of Dermatology, 152, 1182-1186. eScholarID:1d12853 | DOI:10.1111/j.1365-2133.2005.06479.x
    • P van de Kerkhof, Griffiths CEM, E Christophers, M Lebwohl, GG Krueger. (2005). Alefacept in the treatment of psoriasis in patients for whom conventional therapies are inadequate. Dermatology, 211, 256-263. eScholarID:1d12977
    • RF Rose, Bushan M, CM King, Rhodes LE. (2005). Solar angioedema: an uncommonly recognised condition? Photodermatol Photoimmunol Photomed, 21 (5), 226-8. eScholarID:1d10952
    • RG Langley, GG Krueger, Griffiths CEM. (2005). Psoriasis: epidemiology, clinical features, and quality of life. Annals of Rheumatic Diseases, 64, 18-23. eScholarID:1d10942
    • Richards HL, Fortune D, Griffiths CEM, Chris J Main. (2005). Alexithymia patients with psoriasis; clinical correlates and psychometric properties of the TAS-20. Journal of Psychosomatic Research, 58, 89-96. eScholarID:1d7820
    • Richards HL, Ray DW, B Kirby, D Mason, Plant D, CJ Main, DG Fortune, Griffiths CEM. (2005). Response of the hypothalamic-pituitary-adrenal axis to psychological stress in patients with psoriasis. British Journal of Dermatology, 153, 1114-1120. eScholarID:1d10837
    • S Kyle, D Chandler, Griffiths CEM, P Helliwell, J Lewis, I McInnes, S Oliver, Symmons D, N McHugh. (2005). BSR Guideline for Anti-TNF(alpha) Therapy in psoriatic arthritis. Rheumatology, 44, 390-7. eScholarID:1d10940
    • SA Ghaffar, SE Clements, Griffiths CEM. (2005). Modern management of psoriasis. 5, 564-568. eScholarID:1d12876
    • Shetty S, Moore TL, Jackson SK, Brettle D, Herrick AL. (2005). A pilot study of acetic acid iontophoresis and ultrasound in the treatment of systemic sclerosis-related calcinosis. Rheumatology, 44, 536-538. eScholarID:1d11094
    • Smith, C, Anstey, A, Barker, J, Burden, A, Chalmers, RJG, Chandler, D, Finlay, A, Griffiths, CEM, Jackson, K, McHugh, N, McKenna, K, Reynolds, N, Ormerod, A, NULL. (2005). British Association of Dermatologists guidelines for use of biological interventions in psoriasis 2005. Br J Dermatol, 153( 3), 486-97. eScholarID:1d11979
    • Storey A, McArdle FM, Friedmann PS, Jackson MJ, Rhodes LE. (2005). Eicosapentaenoic Acid and Docosahexaenoic Acid Reduce UVB- and TNF-a-induced IL-8 Secretion in Keratinocytes and UVB-induced IL-8 in Fibroblasts. J Invest Dermatol, 124(1), 248-255. eScholarID:1d8499 | DOI:10.1111/j.0022-202X.2004.23543.x
    • Trevor N Brooklyn, Giles Dunnill, Ajeya Shetty, Bowden JJ, Jason Williams, Griffiths CEM, Alastair Forbes, Rosemary Greenwood, Chris Probert. (2005). Infliximab for the treatment of pyoderma gangrenosum: a randomised, double-blind placebo-controlled trial. Gut, 55, 505-509. eScholarID:1d12978
    • V Quekenborn-Trinquet, P Fogel, O Aldana-Jammayrac, P Ancian, M Demarchez, Richards, HL, B Kirby, C Nguyen, JJ Voegel, Griffiths, CEM. (2005). Gene expression profiles in psoriasis: analysis of impact of body site location and clinical severity. British Journal of Dermatology, 152, 482-504. eScholarID:1d10939
    • Watson REB, Griffiths CEM. (2005). Pathogenic aspects of cutaneous photoageing. Journal of Cosmetic Dermatology, 4, eScholarID:1d11085
    • Winhoven S, Griffiths CEM. (2005). What GPs need to know about TNF-alpha inhibitors. Dermatology in Practice, 13, 22-24. eScholarID:1d11185
    • Young H, Griffiths CEM. (2005). Efalizumab: a viewpoint. Americal Journal of Clinical Dermatology, 6, 119-20. eScholarID:1d10938

    Report

    • Seston EM, Ashcroft DM, Griffiths CEM. (2005). Examining patients' preferences for the treatment of psoriasis. eScholarID:5d93
| Skip to main content | Skip to navigation |